Role of Extensive Lymphadenectomy in Early-Stage Cervical Cancer Patients With Radical Hysterectomy Followed by Adjuvant Radiotherapy

被引:10
作者
Tomita, Natsuo [1 ]
Mizuno, Mika [2 ]
Kondo, Shinji [2 ]
Mori, Masahiko [2 ]
Takeshita, Sho [2 ]
Sakata, Jun [2 ]
Tsubouchi, Hirofumi [2 ]
Kodaira, Takeshi [1 ]
机构
[1] Aichi Canc Ctr Hosp, Dept Radiat Oncol, Nagoya, Aichi, Japan
[2] Aichi Canc Ctr Hosp, Dept Gynecol Oncol, Nagoya, Aichi, Japan
关键词
Uterine cervical cancer; Lymph nodes; Radiotherapy; Adjuvant; Lymphadenectomy; LYMPH-NODE COUNT; RISK; CARCINOMA; NUMBER; IRRADIATION; SURVIVAL; CHEMORADIOTHERAPY; METASTASIS; PROGNOSIS; TRIAL;
D O I
10.1097/IGC.0000000000001279
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives The objective of this study was to assess the effect of extensive lymphadenectomy on survival of early-stage cervical cancer patients with radical hysterectomy followed by adjuvant radiotherapy (RT). Materials and Methods A retrospective analysis was performed on early-stage patients with high-risk factors who received radical hysterectomy with lymphadenectomy followed by adjuvant RT. All patients were divided into the less than or equal to 40 dissected pelvic lymph nodes (DPLN 40) and greater than 40 dissected pelvic lymph nodes (DPLN >40) groups to assess the effect of extensive lymphadenectomy. Distributions of disease-free survival (DFS) and overall survival (OS) were calculated by the Kaplan-Meier method. Significance of survival was assessed by the log-rank test. Cox proportional hazards models were applied to assess the effects of the factors on survival by univariate and multivariate analyses. Results After a median follow-up of 76 months for a total of 178 patients, 5-year DFS of the DPLN >40 group was significantly higher than that of the DPLN 40 group (86% vs 74%, P = 0.045). Five-year OS was comparable between the 2 groups (85% vs 78%, P = 0.49). The multivariate analysis showed that the DPLN 40 group was at a significantly higher risk of recurrence (hazard ratio, 2.3; 95% confidence interval (CI), 1.1-4.8; P = 0.020), whereas OS was not affected by the DPLN group (P = 0.26). Positive pelvic lymph node, parametrial invasion, histological type, and the absence of RT-combined chemotherapy remained significant prognostic factors for lower DFS and OS by the multivariate analysis. Adjusted hazard ratio of DPLN 40 for DFS was 1.2 (95% CI, 0.11-12; P = 0.91) in patients with negative pelvic lymph node (PLN) whereas it was 2.6 (95% CI, 1.1-5.8; P = 0.024) in patients with positive PLN. Conclusions These results suggest that more extensive lymphadenectomy significantly improve the outcomes of patients with positive PLN even followed by adjuvant RT.
引用
收藏
页码:1211 / 1217
页数:7
相关论文
共 30 条
  • [1] [Anonymous], UROLOGIC ONCOLOGY SE
  • [2] [Anonymous], 2017, CERVICAL CANC VERSIO
  • [3] Lower Limb Lymphedema and Neurological Complications After Lymphadenectomy for Gynecological Cancer
    Biglia, Nicoletta
    Librino, Armando
    Ottino, Maria Chiara
    Panuccio, Enrico
    Daniele, Alberto
    Chahin, Achtari
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (03) : 521 - 525
  • [4] Lymph node evaluation and survival after curative resection of colon cancer: Systematic review
    Chang, George J.
    Rodriguez-Bigas, Miguel A.
    Skibber, John M.
    Moyer, Virginia A.
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (06) : 433 - 441
  • [5] Chatani M., 1995, Strahlentherapie und Onkologie, V171, P655
  • [6] The Role of Lymphadenectomy in Cervical Cancer Patients: The Significance of the Number and the Status of Lymph Nodes Removed in 526 Cases Treated in a Single Institution
    Ditto, Antonino
    Martinelli, Fabio
    Lo Vullo, Salvatore
    Reato, Claudio
    Solima, Eugenio
    Carcangiu, Marialuisa
    Haeusler, Edward
    Mariani, Luigi
    Lorusso, Domenica
    Raspagliesi, Francesco
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (12) : 3948 - 3954
  • [7] Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer
    Gajra, A
    Newman, N
    Gamble, GP
    Kohman, LJ
    Graziano, SL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) : 1029 - 1034
  • [8] IS PROPHYLACTIC PARA-AORTIC IRRADIATION WORTHWHILE IN THE TREATMENT OF ADVANCED CERVICAL-CARCINOMA - RESULTS OF A CONTROLLED CLINICAL-TRIAL OF THE EORTC RADIOTHERAPY GROUP
    HAIE, C
    PEJOVIC, MH
    GERBAULET, A
    HORIOT, JC
    POURQUIER, H
    DELOUCHE, J
    HEINZ, JF
    BRUNE, D
    FENTON, J
    PIZZI, G
    BEY, P
    BROSSEL, R
    PILLEMENT, P
    VOLTERRANI, F
    CHASSAGNE, D
    [J]. RADIOTHERAPY AND ONCOLOGY, 1988, 11 (02) : 101 - 112
  • [9] Clinical Efficacy of Alternating Chemoradiotherapy by Conformal Radiotherapy Combined with Intracavitary Brachytherapy for High-risk Cervical Cancer
    Hirata, Kimiko
    Kodaira, Takeshi
    Tomita, Natsuo
    Ohshima, Yukihiko
    Ito, Junji
    Tachibana, Hiroyuki
    Nakanishi, Toru
    Fuwa, Nobukazu
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (06) : 556 - 563
  • [10] JEMAL A, 2011, CA-CANCER J CLIN, V61, P134, DOI [DOI 10.3322/CAAC.20107, DOI 10.3322/caac.20115]